Articles written for the GLP list the source as Genes and Science. All other articles were written for the sources noted with excerpts provided by the GLP.
genetic blood disorders g rf x

Gene therapy for hemophilia delayed until 2022 after FDA rejects one-time treatment, shocking doctors and scientists

ABC News, Genes and Science&nbsp|&nbsp
U.S. regulators rejected [Biomarin’s] potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime ...